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Abstract
The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated
macaques is delayed for 15-20 weeks, a process that is related to qualitative changes in
CD8+ T cell responses induced by SIVΔnef. As a novel approach to characterize cell differ-
entiation following vaccination, we used multi-target qPCR to measure transcription factor
expression in naïve and memory subsets of CD8++ T cells, and in SIV-specific CD8+ T cells
obtained from SIVΔnef-vaccinated or wild type SIVmac239-infected macaques. Unsuper-
vised clustering of expression profiles organized naïve and memory CD8+ T cells into
groups concordant with cell surface phenotype. Transcription factor expression patterns in
SIV-specific CD8+ T cells in SIVΔnef-vaccinated animals were distinct from those observed
in purified CD8+ T cell subsets obtained from naïve animals, and were intermediate to ex-
pression profiles of purified central memory and effector memory T cells. Expression of tran-
scription factors elicited by SIVΔnef vaccination also varied over time: cells obtained at later
time points, temporally associated with greater protection, appeared more central-memory
like than cells obtained at earlier time points, which appeared more effector memory-like.
Expression of transcription factors associated with effector differentiation, such as ID2 and
RUNX3, were decreased over time, while expression of transcription factors associated
with quiescence or memory differentiation, such as TCF7, BCOR and EOMES, increased.
CD8+ T cells specific for a more conserved epitope expressed higher levels of TBX21 and
BATF, and appeared more effector-like than cells specific for an escaped epitope, consis-
tent with continued activation by replicating vaccine virus. These data suggest transcription
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factor expression profiling is a novel method that can provide additional data complementa-
ry to the analysis of memory cell differentiation based on classical phenotypic markers. Ad-
ditionally, these data support the hypothesis that ongoing stimulation by SIVΔnef promotes
a distinct protective balance of CD8+ T cell differentiation and activation states.
Author Summary
The live attenuated vaccine SIVΔnef can induce robust CD8+ T cell- mediated protection
against infection with pathogenic SIV in macaques. Thus, there is substantial interest in
characterizing these immune responses to inform HIV vaccine design. Animals challenged
at 15–20 weeks post vaccination exhibit robust protection, whereas animals challenged at
5 weeks post-vaccination manifest little protection. Since the frequency of SIV-specific T
cells decreases from week 5 to week 20, it is likely that the quality of the response to chal-
lenge changes as virus-specific cells differentiate. We applied a novel approach of tran-
scription factor expression profiling to characterize the differences in SIV-specific cell
function and phenotype at more protected and less protected time points. Using unsuper-
vised clustering methods informed by expression profiles assessed in purified CD8+ T cell
subsets, we show that SIV-specific cells display expression profiles different than any puri-
fied CD8+ T cell subset, and intermediate to sorted effector memory and central memory
subsets. SIV-specific cells overall appear more effector memory-like at week 5 post-
vaccination, and more central memory-like at week 20 post-vaccination. Distinct profiles
of CD8+ T cells specific for different SIV epitopes having different immune escape kinetics
suggests maturation is regulated by ongoing low-level replication of vaccine virus.
Introduction
Vaccination of rhesus macaques with SIVΔnef can induce robust immune responses and can
protect the majority of vaccinated animals from challenge with wild-type SIV virus strains
[1–3]. To date, SIVΔnef is the most efficacious of all vaccine strategies analyzed in the macaque
model. Although safety concerns preclude the use of attenuated HIV as a human vaccine [4,5],
understanding the biological basis for immune protection conferred by SIVΔnef may provide
information important for the design of safe and efficacious HIV vaccines. Therefore, substan-
tial efforts have been made to identify correlates of immune protection induced by SIVΔnef
over the last two decades.
Correlates of immune protection induced by SIVΔnef and related attenuated SIV vaccines
identified to date include both cellular and humoral adaptive immune responses [3,6–10].
CD8+ T cell responses in particular appear to be critical for SIVΔnef-mediated protection.
SIVΔnef can induce robust CD8+ CTL responses and protection can occur in the absence of
neutralizing antibody responses [3,7]. Additionally, CD8+ cell depletion following vaccination
with attenuated SIV vaccines results in impaired control of challenge virus [6,11]. Although
the vaccine virus is rapidly cleared to levels in plasma that are at or below detection following
vaccination in the majority of animals [1], virus continues to replicate at low levels [12,13].
Substantial evidence suggests that the replicative capacity of SIVΔnef, and the ability to provide
persistent low-level antigenic stimulation, may mediate the high efficacy of protection [3,12–
14]. A comparison of SIVΔnef with more-attenuated SIV virus strains found a positive correla-
tion of the magnitude of lymph-node resident SIV-specific T cells to protection from
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intravenous challenge [13]. However, SIVΔnef does not induce greater numbers of SIV-specific
CD8+ T cells than other vaccine approaches that do not induce protection [15–17]. Additional-
ly, the frequency of SIVΔnef-induced SIV-specific CD8+ T cells located in lymphoid and geni-
tal tissues does not correlate with the maturation of protection in this model [12]. The
frequency or magnitude, therefore, of virus-specific precursors in blood and tissues may be less
important for immune control than the composition of CD8+ T cell memory phenotypes in-
duced by SIVΔnef. Immune protection takes approximately 15–20 weeks to develop following
vaccination [18] and during that time, SIV-specific T cells acquire a more central memory-like
phenotype but maintain elevated PD-1 expression [14]. Persistent expression of PD-1 on SIV-
specific CD8+ T cells requires ongoing low-level viral replication, as PD-1 expression is down
regulated on cells specific for an epitope that undergoes escape [14]. These data, in conjunction
with evidence of viral evolution following vaccination [1,19–21] and evidence that ongoing
replication is required for vaccine efficacy, suggest that continued stimulation from viral epi-
topes present due to ongoing low-level replication of vaccine virus may induce a unique differ-
entiation or activation state of SIV-specific CD8+ T cells. SIVΔnef may also promote a balance
or distribution of central memory and effector cells, or a T cell repertoire different than that in-
duced by less protective vaccines. A complete understanding of how SIVΔnef-induced CD8+ T
cells mediate protection, and the relationship between CD8+ T cell differentiation stage and
protective immunity remains unclear. Novel experimental methods that can provide additional
information to what can be acquired with traditional approaches such as polychromatic flow
cytometry may facilitate a more complete characterization of immune protection.
In the past decade, substantial progress has been made in characterizing the differentiation
of CD8+ effector and memory cell subsets following antigenic stimulation [22]. Genetic ap-
proaches have demonstrated the importance of a number of individual transcription factors in
regulating differentiation. However, the combinatorial expression of lineage-specific and gen-
eral transcription factors and their aggregation at cis-regulatory elements dictate the expression
of any specific gene and ultimately the phenotype of the cell [23–25]. Recognition of the combi-
natorial nature of transcription factor function has motivated a more holistic approach to un-
derstanding transcription factor function and prompted a number of comprehensive systems
based descriptions of differential transcription factor usage and networks of transcriptional
control in different tissues and cell lineages including the hematopoietic system [23,24,26,27].
To expand on the current capacity for cell phenotypic and functional analyses provided by
methods such as polychromatic flow cytometry, we developed a novel approach that exploits
the fundamental regulation of cell phenotype and function by combinatorial transcription fac-
tor activity. We reasoned that simultaneous expression profiling of multiple transcription fac-
tors known to regulate cell differentiation could facilitate discrimination of cell lineage and
provide novel information complementary to other methods. To assess the utility of transcrip-
tion factor expression profiling for the characterization of CD8+ T cell differentiation, we mea-
sured the expression of a panel of transcription factors known to regulate T cell differentiation
in sorted bulk populations of naïve and memory CD8+ T cells and in SIV-specific cells induced
by SIVΔnef vaccination. Subsequent organization of samples by unsupervised clustering of ex-
pression data indicates that transcription factor expression profiling is a sensitive method that
can clearly identify cells at different stages of CD8+ T cell differentiation. We subsequently ap-
plied this method to further characterize the differentiation of CD8+ T cells induced by SIVΔ-
nef, and to characterize the phenotype of CD8+ T cells temporally associated with either
protective, or non-protective immune responses. Our data demonstrate the utility of transcrip-
tion factor expression profiling to characterize the differentiation of CD8+ T cells following
SIVΔnef vaccination, and indicate that SIV-specific CD8+ T cells appear to be transcriptionally
intermediate to, yet clearly distinct from, purified effector memory and central memory T cells
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isolated from vaccine-naïve animals. Taken together, our results support the conclusion that
ongoing activation of CD8+ T cells by replicating vaccine virus may induce populations of
CD8+ T cells possessing phenotypic characteristics distinct from, but with similarities to, classi-
cally defined effector memory and central memory cells.
Results
Transcription factors selected for expression profiling
To examine whether expression profiling of multiple transcription factors would facilitate dis-
crimination of different CD8+ T cell differentiation states, we initially selected a panel of 18
transcription factors to analyze (Table 1) based on published data indicating their involvement
in the regulation of CD8+ T cell differentiation or function. A subset of these transcription fac-
tors, such as T-bet, Eomes, Blimp-1 and Id2 are well-characterized primary regulators of CD8+
memory or effector cell differentiation [28–36]. Another set of transcription factors, including
BATF, Runx3 and BCL11b, regulate expression of the transcription factors noted above that
Table 1. Transcription factors analyzed in bulk and SIV-speciﬁc CD8+ T cells.
Gene
Symbol
Transcription
Factor
Function
PRDM1 Blimp-1 Represses IL-2 expression, Bcl-6 antagonist, promotes effector
differentiation [32,33]
TBX21 T-bet Promotes CD8 effector differentiation [28,29]
EOMES Eomesodermin Required for early CD8 effector function and subsequent memory CD8
differentiation [30,31]
BCL6 Bcl-6 Induces central memory differentiation, functions reciprocally to Blimp-
1 [55,61]
BCOR BCoR Bcl-6 corepressor [54]
TCF7 Tcf-7 (Tcf-1) Wnt effector, promotes quiescence, downregulated with antigen
stimulation, promotes Eomes expression [44,45]
LEF1 Lef-1 Wnt effector, promotes quiescence, downregulated with antigen
stimulation [44]
RORC Rorγt Represses IFNγ expression, functions as transcriptional repressor in
naïve or memory CD8 T cells [46,49]
AHR AHR Regulates lymphoid tissue inducing function of innate lymphoid cells
[84,85]
RORA Rorα Promotes effector responses in activated CD8 cells [46]
BATF BATF Upregulated by PD-1 signaling, promotes Rorγt and T-bet expression,
regulates effector differentiation; upregulated in exhausted CD8 cells
[37–39]
PBX3 PBX3 Mediates locus accessibility, upregulated in exhausted CD8 cells
[86,87]
BCL11B BCL11b Regulates Runx3 and FoxP3, promotes cytolytic effector function
[41–43]
RUNX3 Runx3 Promotes expression of T-bet and Eomes, IFNγ, perforin, granzyme B
[40]
GATA3 GATA3 Required for sustained TCR-mediated signaling and CTL activity [48]
ID2 Id2 Promotes CD8 effector memory differentiation [34–36]
IRF4 IRF4 Induced by antigen receptor signaling, represses Eomes, promotes
Blimp-1 expression; cooperatively regulates effector differentiation with
BATF [39,56,88,89]
NFIL3 NFIL3 Activates IL-3 promoter, essential for intraepithelial lymphocyte
development [90,91]
doi:10.1371/journal.ppat.1004740.t001
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serve as regulators of T cell function [37–43]. A third group, the Wnt signaling pathway effec-
tor transcription factors Lef-1 and Tcf-7 (also known as Tcf-1), are positive regulators of quies-
cence [44,45]. A fourth set of transcription factors, Rorα, Rorγt and GATA3, regulate
differentiation of additional T cell lineages and CD8+ T cell activation and effector function
[46–49].
Transcription factors are differentially expressed in sorted CD8+ T cell
subsets
To determine if transcription factor expression profiling can be used to identify distinct stages
of CD8+ T cell differentiation, we initially sorted highly purified populations of naïve, central
memory, transitional memory, and effector memory CD8+ T cells from five healthy unvacci-
nated uninfected rhesus macaques based on differential surface expression of CD28, CD95 and
CCR7 (S1 Fig., Fig. 1). We then measured the expression of the transcription factors included
Fig 1. Segregation of sorted CD8+ T cell subsets by unsupervised hierarchical clustering.Heat map
expression values were transcript mean centered and represent expression relative to endogenous controls.
Hierarchical clustering was performed using Euclidean distance and complete linkage methods.
doi:10.1371/journal.ppat.1004740.g001
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in our panel by multi-target qPCR, and used agglomerative unsupervised hierarchical cluster-
ing of the expression data to organize the samples. The sample dendrogram (Fig. 1) demon-
strates clear segregation of samples by cell differentiation stage, with the three memory CD8+
T cell subsets segregating from naïve cells.
Distinct sets of transcription factors displayed unique expression profiles among cell subsets
(Fig. 2). The Wnt pathway effectors LEF1 and TCF were expressed at the highest levels in naïve
and central memory cells, and lower levels in transitional and effector memory cells. The tran-
scription factors TBX21, PRDM1 and NFIL3, were expressed at the highest levels in effector
memory cells. In contrast, EOMES, AHR and RORC, were expressed at the highest level in tran-
sitional memory cells.
All of the transcription factors except IRF4 and BCL11B were expressed differentially
among the CD8+ T cell subsets (p0.001). The differences in expression levels varied widely
among transcription factors with some transcription factors demonstrating up to 1000-fold dif-
ferences in mean expression level between sorted cell populations.
Unsupervised clustering of samples by differentiation stage demonstrates that expression
profiling of transcription factors is a sensitive method that can be used to clearly resolve dis-
tinct stages of memory CD8+ T cell differentiation.
Fig 2. Differential expression of transcription factors in CD8+ naïve andmemory T cell subsets. log2
mean expression values were normalized to naïve cell samples.
doi:10.1371/journal.ppat.1004740.g002
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SIV-specific CD8+ T cells isolated at week 5 or week 20 post-vaccination
with SIVΔnef have distinct expression profiles
Longitudinal studies suggest that vaccine-induced protection to pathogenic virus challenge ma-
tures during the weeks following vaccination [2,11,18,50]. Animals challenged at 15 to 20
weeks following vaccination are better protected than animals challenged at five weeks follow-
ing vaccination. As transcription factor expression profiling was able to differentiate between
sorted naïve and memory T cell subsets, we sought to use this approach to identify differences
in transcription factor usage in SIV-specific CD8+ T cells isolated at time points following
SIVΔnef vaccination associated with either lesser or greater protection, and to further charac-
terize the phenotype of these cells by comparing their transcription factor expression profiles
with the profiles of sorted naïve and memory CD8+ T cell subsets. We analyzed CD8+ T cells
specific for either of two Mamu-A01-restricted immunodominant SIV epitopes differing in
their propensity for immune escape. The Gag CM9 epitope is typically conserved over time
[51], whereas the Tat SL8 epitope mutates rapidly following infection in response to immune
pressure, beginning to accumulate sequence heterogeneity at two weeks post infection [52,53].
We hypothesized that the distinct escape kinetics and resulting sensitivities to ongoing antigen-
ic stimulation would induce differences in differentiation stage resolvable by transcription fac-
tor expression profiling. We sorted Gag CM9- and Tat SL8- specific CD8+ T cells obtained
from four rhesus macaques at either 5 weeks or 20 weeks following SIVΔnef vaccination, and
measured the expression levels of the transcription factors in our target panel by multi-target
qPCR.
To integrate the expression profiles of the SIV-specific cells with the sorted CD8+ subsets,
we applied principal component analysis (PCA) to the combined data sets. Plotting principal
components 1 vs, 2, and principal components 2 vs. 3, (PC1, PC2, PC3; Fig. 3A, S1 Video) seg-
regated the data into distinct clusters. The data points representing the sorted CD8+ T cells oc-
cupy the periphery of the PC1 vs. PC2 plot, and segregate into separate clusters based upon cell
differentiation stage. The naïve cells segregate from the memory cells along the PC1 axis,
whereas the memory cells segregate along the PC2 axis, with the transitional memory cells po-
sitioned intermediately between the central and effector cells. The PC1 and PC2 loading factors
(Fig. 3B) indicate that in this analysis, differential expression of LEF1, TCF7, PRDM1 and
TBX21 strongly influence segregation of naïve from memory cells, whereas differential expres-
sion of ID2, RUNX3, AHR and LEF1 strongly influence segregation of memory cell subsets.
The SIV-specific CD8+ T cells cluster with the sorted memory cells on the PC1 axis, and are po-
sitioned intermediately between central memory and effector memory cells on the PC2 axis.
This intermediate position on the PC2 axis in part reflects the combined expression profiles of
different memory subsets present in the SIV-specific cell samples. However, the SIV-specific
samples significantly segregate from any sorted memory subset, particularly on the PC3 axis
(p<0.001), indicating that the transcription factor expression profiles of the SIV-specific cells
are distinct from the sorted subsets and are not solely comprised of proportions of memory
subsets. The PC3 loading factors (Fig. 3B) indicate that in this analysis, the differential expres-
sion of NFIL3, IRF4, LEF1 and EOMES influence segregation of SIV-specific cells from the
sorted naïve and memory subsets. The SIV-specific cells form two clusters, generally organized
by week post-infection. The week 5 and week 20 post-vaccination samples occupy significantly
different positions in PCA space (p<0.01). The week 5 post-vaccination cells, temporally asso-
ciated with less protection to challenge, have greater PC2 values, indicating a more effector-like
profile, whereas the week 20 post-vaccination cells have lesser PC2 values indicating a more
central-memory like profile. The samples also significantly segregate based on epitope specifici-
ty (p<0.01). The Gag CM9-specific cells have overall higher PC2 values indicating a more
Transcription Factor Expression Profiling of SIV-Specific CD8+ T Cells
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effector-like phenotype, whereas the Tat SL8-specific cells have lower PC2 values indicating a
more central memory-like phenotype. The changes in expression profiles from week 5 to week
20 are consistent with SIV-specific CD8+ T cells becoming overall more central memory-like
and less effector-like over time following vaccination. Similarly, the differences seen between
Gag CM9- and Tat SL8-specific cells are consistent with the kinetics of epitope escape and like-
ly reflect the loss of antigen stimulation of the Tat-specific cells versus the ongoing stimulation
of the Gag-specific cells.
To further validate the approach of using transcription factor expression profiling to charac-
terize cell differentiation, we compared this method to conventional flow-cytometric assess-
ment of CD8+ T cell memory subsets present in SIV-specific populations at different time
points following vaccination. In agreement with our expression profiling methods, flow cyto-
metric methods based on differential expression of CCR7 and CD28 showed an overall increase
in CM cells and a decrease in EM cells from week 5 to week 20 post-vaccination. Furthermore,
Fig 3. Principal component analysis of transcription factor expression profiles from SIV-specific MHC tetramer-sorted CD8+ T cells and sorted
CD8+ T cell subsets. (A) Plot of principal components 1 vs. 2, and 2 vs. 3 for each of the expression profiles assessed in sorted naïve and memory CD8+ T
cell subsets isolated from healthy control animals (n = 5), and SIV-specific MHC tetramer-sorted CD8+ T cells isolated from animals (n = 4) at week 5 or week
20 following SIVΔnef vaccination. Principal components 1, 2 and 3 explain 92% of cumulative total variance. (B) PCA loading factors for each
transcription factor.
doi:10.1371/journal.ppat.1004740.g003
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Tat SL8-specific cells had greater frequencies of CM cells and lesser frequencies of EM cells
than Gag CM9-specific cells (S2A Fig.). Additionally, the ratio of EM to CM cells found in a
sample of SIV-specific cells positively correlates with the PC2 value of the combined PCA anal-
ysis (S2B Fig.).
To provide additional context for interpreting SIV-specific CD8+ T cell expression profiles,
and to further examine the effect of ongoing viral replication on transcription factor expression
profiles, we used PCA to compare vaccine-specific and sorted naïve and memory subsets to
SIV-specific CD8+ T cells collected at week 20 following infection with pathogenic wild-type
SIV.
A plot of principal components 1 and 2 (Fig. 4) positioned Gag CM9-specific cells obtained
from wild-type SIV-infected animals near the sorted effector memory cells but with higher
PC2 values. Tat SL8-specific cells from wild-type SIV-infected animals were more heteroge-
neous but generally occupied positions more positive along the PC2 axis than SIVΔnef-induced
cells, with PC2 values similar to sorted effector memory cells. These results are consistent with
the idea that ongoing activation by replicating virus may induce a more effector-like pheno-
type, and that epitope escape facilitates a more central memory-like phenotype.
A number of individual transcription factors were significantly differentially expressed be-
tween week 5 post-vaccination and week 20 post-vaccination (Fig. 5). For example BCOR,
EOMES and TCF7 were expressed at significantly higher levels at week 20 post-vaccination.
Higher expression of these transcription factors is consistent with a more quiescent and central
memory-like phenotype [44,45,54]. Conversely, ID2, RORA, NFIL3 and RUNX3 were
Fig 4. Principal component analysis of transcription factor expression profiles from SIV-specific MHC
tetramer-sorted CD8+ T cells from animals vaccinated with SIVΔnef, animals infected with wild-type
SIV, and sorted CD8+ T cell subsets. Plot of principal components 1 and 2 for each of the expression
profiles assessed from sorted naïve and memory CD8+ T cell subsets, SIV-specific MHC tetramer-sorted
CD8+ T cells isolated from SIVΔnef-vaccinated animals, and MHC tetramer-sorted CD8+ T cells isolated from
animals (n = 5) at 20 weeks following wild-type SIV infection. Principal components 1 and 2 explain 77
percent of cumulative total variance.
doi:10.1371/journal.ppat.1004740.g004
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expressed at significantly lower levels at week 20 post-vaccination. Lower expression of ID2
and RUNX3 is also consistent with a more central memory-like phenotype [35,40]. Elevated
TBX21 expression, which is associated with effector differentiation, however, was maintained
at week 20, consistent with continued effector function [28,29].
A number of transcription factors were also significantly differentially expressed between
Gag CM9- and Tat SL8- specific cells. Gag-specific CD8+ T cells expressed significantly higher
levels of BATF, TBX21 and RORA. These differential expression profiles are consistent with
Gag CM9-specific cells maintaining a more effector-like phenotype than Tat SL8-specific cells
[28,37,46]. Interestingly, EOMES was expressed at significantly lower levels in Gag CM9-
specific cells than in Tat SL8-specific cells at week 5 post-vaccination, and a trend towards
higher expression was observed in Gag CM9-specific cells than in Tat SL8-specific cells at week
20 post-vaccination. Conversely, ID2 is expressed at significantly higher levels at week 5 in
Fig 5. Differential expression of transcription factors in CD8+ T cells isolated at week 5 and week 20 post-vaccination with SIVΔnef and at week 20
post-infection with wild-type SIV. Symbols indicate log2 expression relative to endogenous controls in cells from individual animals. Red symbols indicate
Gag CM9-specific cells, blue symbols indicate Tat SL8-specific cells. Sample means are indicated by horizontal bars. Statistically significant (p0.05)
differences in transcription factor expression between cells from week 5 and week 20 post-SIVΔnef vaccination, or between cells from week 20 post-SIVΔnef
vaccination and week 20 post-wild-type SIV infection are indicated by horizontal bars with asterisks. Statistically significant differences between Gag CM9
and Tat SL8-specific cells are indicated by vertical bars with asterisks.
doi:10.1371/journal.ppat.1004740.g005
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Gag-specific cells and more similar to Tat-specific cells at week 20. These trends are consistent
with Tat-specific cells being more central memory-like even at the earlier time point [31,35].
Many of the transcription factors were differentially expressed between SIV-specific CD8+
T cells in wild-type SIV- and SIVΔnef-infected animals at week 20 post-vaccination, likely re-
flecting the higher viral loads and attendant greater stimulation of SIV-specific cells in animals
infected with wild-type SIV. EOMES, ID2 and RUNX3 were expressed at significantly higher
levels in cells from wild-type SIV-infected animals (p 0.05). In contrast, AHR and LEF1 were
expressed at significantly lower levels in wild-type SIV-specific cells. A number of transcription
factors were differentially expressed between Gag- and Tat-specific cells in wild-type SIV-in-
fected animals. In particular, the Wnt pathway effectors TCF7 and LEF1, as well as BCL6, had
significantly higher expression in Tat-specific cells. In contrast, EOMES, RUNX3 and IRF4
demonstrated trends towards higher expression in Gag-specific cells. These differences are
consistent with the different kinetics of epitope escape, and consistent with loss of antigen stim-
ulation mediating cell differentiation towards a less activated or more central memory pheno-
type [11,12,44,55,56].
Overall, the differences we observed in transcription factor expression profiles suggest that
the process of CD8+ T cell differentiation following SIVΔnef vaccination involves the coordi-
nate regulation of multiple transcription factors. At later time points following vaccination,
SIV-specific cells express higher levels of transcription factors associated with memory differ-
entiation, such as EOMES and TCF7, down-regulate transcription factors associated with effec-
tor responses such as ID2 and RUNX3, yet maintain elevated levels of TBX21.
To facilitate comparison of expression levels of individual transcription factors in the differ-
ent populations of T cells, we also generated a PCA heatmap (Fig. 6) of each transcription factor
by overlaying expression values as heatmap colors on a plot of principal components 1 and 2.
The PCA heatmaps demonstrate that expression of PRDM1 and TBX21 in SIV-specific cells
is similar to central memory or transitional memory cells. In contrast, expression of EOMES,
TCF7, GATA3 and BCL6 in SIV-specific cells is more similar to effector memory cells. Expres-
sion of AHR, ID2, RUNX3 and LEF1 in SIV-specific cells is intermediate between central mem-
ory and effector memory cells. Interestingly, expression of the transcription factors BATF,
BCOR, RORA, NFIL3, IRF4 and PBX3 is greater in SIV-specific cells than any sorted subset.
The higher expression levels of these transcription factors in SIV-specific cells provides addi-
tional evidence that the SIV-specific cells are transcriptionally distinct from any purified mem-
ory subset, or proportion of subsets. Although statistically significant for only PBX3 (p<0.05)
these trends of increased expression may, in part, reflect ongoing stimulation from
replicating virus.
Discussion
Memory T cells display substantial heterogeneity in phenotype, function and anatomic distri-
bution [57]. The characterization of memory cell differentiation and the definition of pheno-
typic memory cell subpopulations has traditionally employed flow cytometric analyses of a
subset of cell surface proteins, which regulate cell activation, survival and tissue-homing
[58–60]. Over the past decade, the characterization of molecular mechanisms regulating mem-
ory differentiation has also identified key transcription factors that modulate the gene expres-
sion profiles in differentiating cells and cell subpopulations [22]. As transcription factors
fundamentally regulate cell phenotype and function, global analyses of differential transcrip-
tion factor usage accompanying cell differentiation can conceptually both identify novel sub-
populations of cells not resolvable by standard flow cytometric techniques and provide novel
insights into the process of cell differentiation and the function of cell subpopulations.
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We validated this approach by initially characterizing the transcription factor expression
profiles of CD8+ T cells isolated at different stages of CD8+ T cell differentiation, and we subse-
quently used these data to characterize CD8+ T cells induced by SIVΔnef vaccination and wild-
type SIV infection. Clustering analyses of transcription factor expression data verified that
CD8+ T cells purified by traditional flow cytometric gating strategies display distinct transcrip-
tion factor expression profiles. This strict segregation by differentiation state, of cells from all
animals is striking, given that rhesus macaques are outbred animals and would be expected to
display substantial transcriptional heterogeneity between individuals. The three memory sub-
sets had transcription factor expression profiles more similar to each other than to naive cells,
and the transitional memory cells appeared more similar to central memory cells than to effec-
tor memory cells. The expression profiles across subsets corroborates, for many of the tran-
scription factors, patterns of expression that have been reported for single transcription factors
or small subsets of transcription factors, although comprehensive analyses of expression of
multiple transcription factors have not previously been undertaken. TBX21, PRDM1, RUNX3
and ID2, for example, were expressed at higher levels in sorted effector memory cells, whereas
Fig 6. Principal component analysis heat maps of transcription factor expression profiles from SIV-
specific MHC tetramer-sorted CD8+ T cells from animals vaccinated with SIVΔnef, and sorted naïve
andmemory CD8+ T cells.Heat map log2 relative expression values were range normalized for each
transcription factor.
doi:10.1371/journal.ppat.1004740.g006
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the Wnt pathway effectors LEF1 and TCF7 were expressed at higher levels in the more quies-
cent naive and central memory cells. The high ratio of TBX21 to EOMES observed in effector
memory cells, and similarly, the high ratio of PRDM1 to BCL6 observed in transitional memory
and effector memory cells is consistent with the promotion of an effector phenotype [61].
Given the caveat that differences in transcription do not always directly correlate with differ-
ences in protein expression or function, overall, these results validate the approach of using
transcription factor expression profiling to define the memory differentiation state of CD8+
T cells.
We subsequently used transcription factor expression profiling to characterize changes in
SIV-specific CD8+ T cells over time as immune protection to challenge matures following vac-
cination. Half of the transcription factors assessed had significantly different (p0.05) expres-
sion levels at week 20 than at week 5 post-vaccination, and segregation by PCA suggested that
SIV-specific cells had substantially different expression profiles at the two time points. SIV-
specific CD8+ T cells in SIVΔnef-vaccinated animals at week 20 displayed a transcriptional sig-
nature characteristic of (but not identical to) central memory cells, as manifested by elevated
levels of TCF7 and EOMES and decreased expression of ID2 and RUNX3. Importantly, because
transcription was assessed in bulk populations of cells, differences between levels of expression,
and location in PCA space reflect both differences between expression levels on a per-cell basis,
and differences in proportions of subsets present in the sample. Thus, the more central memo-
ry-like expression profile displayed at week 20 post-vaccination likely reflects the greater pro-
portion of central memory-like cells present at week 20 post-vaccination, in agreement with
our conventional flow cytometric analyses, but may also reflect a more central-memory like
profile in SIV-specific cells overall.
A number of transcription factors were also differentially expressed between cells with dif-
ferent epitope specificities and immune escape kinetics. For example, TBX21 and BATF were
expressed at higher levels in Gag CM9-specific cells than in Tat SL8-specific cells. Since BATF
is upregulated downstream of PD-1 signaling [38], this observation is consistent with the
higher levels of PD-1 expressed on Gag CM9-specific cells than in Tat SL8-specific cells [14].
The role of PD-1 in promoting an exhausted T cell phenotype in the setting of chronic viral in-
fection has been widely described [62,63]. However, the expression of PD-1 is not an indication
in itself of an exhausted phenotype and more accurately reflects cell activation [13,14,64].
Overall, the Tat SL8-specific cells appeared less activated and more memory-like than the Gag
CM9-specific cells. Although differences in expression profiles between Gag CM9- and Tat
SL8-specific cells are likely to be influenced by a variety of variables, the differences we ob-
served are consistent with the loss of antigenic stimulation due to the evolution of escape in the
Tat SL8 epitope, and on-going stimulation of Gag CM9-specific cells. These results are also
consistent with prior work demonstrating a decline in the frequency of activated Tat
SL8-specific cells, but not Gag CM9-specific cells in genital tissue from 5 to 20 weeks post-
vaccination with SIVΔnef [12].
SIV-specific cells from wild-type SIV-infected animals displayed a pattern of expression of
transcription factors more characteristic of effector memory cells than SIV-specific cells from
SIVΔnef-vaccinated animals. Gag CM9-specific cells more closely resembled effector memory
cells in expression of transcription factors than Tat SL8-specific cells, as predominantly re-
flected by their differential expression of LEF1 and TCF7. Further, LEF1 was expressed at over-
all lower levels in cells from wild-type-infected animals than SIVΔnef-vaccinated animals,
mainly due to very low expression in the Gag CM9-specific cells. This difference likely reflects
the much higher levels of antigen stimulation in wild-type SIV-infected animals. BATF was
also expressed at lower levels in cells from wild-type-infected animals than in cells from SIVΔ-
nef-vaccinated animals. Since BATF has recently been shown not only to promote effector
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differentiation, but also to restrain the expression of the effector molecules IFNγ and granzyme
B [39], the reduced expression observed in wild-type-infected animals may reflect reduced in-
hibition of effector molecule expression in the presence of high viral loads. Overall, these re-
sults are consistent with previous studies suggesting virus-specific cells continue to be activated
by replicating virus, and that CTL escape is associated with reduced cell activation and central
memory differentiation [3,12–14].
Studies in macaques using the live-attenuated SHIV89.6 vaccine suggest that protection
against vaginal challenge is associated with the presence of SIV-specific CD8+ T cells in the fe-
male reproductive tract that possess both cytolytic function and some proliferative capacity
[65,66]. Earlier studies showed that protection was associated with a higher ratio of central
memory to effector memory CD8+ T cells in blood and lymph nodes [67]. CD8+ T cells from
protected animals also showed higher pre-challenge measures of survival and lower apoptotic
potential. In contrast to the effector memory cells found in the female reproductive tract, IL-2
secreting SIV-specific CD8+ T cells were found in lymph nodes. Overall this suggests a model
whereby in protected animals, SHIV89.6 induces central memory CD8+ T cells that continually
supply effector cells to the genital mucosa in response to persistent antigenic stimulation by
replicating virus. That unprotected animals have a higher ratio of effector memory to central
memory cells in blood and lymph nodes suggests that lack of protection may be associated
with heightened systemic T cell activation and resultant apoptosis and exhaustion.
In the setting of spontaneously controlled HIV infection, overwhelming evidence suggests
CD8+ T cell activity is critical for viral suppression. However there has been substantial hetero-
geneity reported in ex vivo measures of CD8+ T cell function in controllers. Studies have vari-
ously shown associations between control of viremia and CD8+ T cell polyfunctionality, HIV-
specific CD8+ T cell frequency, virus suppressive capacity, or proliferative capacity [68–72]. A
more recent study [73] examined individuals who control viremia to very low levels in the ab-
sence of ex vivo CD8+ T cell responses (weak responders), and found that these subjects main-
tain an HIV-specific population of central memory CD8+ T cells capable of suppressing HIV ex
vivo. An additional study [74] showed that spontaneous protection from HIV in controllers cor-
relates with CD8+ T cell memory-type responses, prolonged cytokine secretion, and cell prolifer-
ation. In the setting of elite control and very low viremia, HIV-specific T cells may receive less
antigenic stimulation facilitating differentiation towards a more central memory phenotype.
Our data demonstrate the utility of using transcription factor expression profiling to charac-
terize the differentiation of CD8+ T cells following vaccination with SIVΔnef. Using this ap-
proach we demonstrate that SIV-specific cells isolated from vaccinated animals at time points
associated with greater immune protection display a distinct pattern of expression of transcrip-
tion factors that represent the presence of different proportions of CD8+ T cell memory sub-
sets, or different levels of activation or differentiation states. The higher expression levels of a
number of transcription factors in SIV-specific cells than in any purified memory subset sug-
gests that continued activation of subsets of virus-specific cells by low-level replicating virus in-
duces transcriptionally distinct populations of CD8+ T cells which may have characteristics of
both central memory and effector memory cells.
Materials and Methods
Ethics statement
The 14 female Indian-derived rhesus macaque monkeys (Macaca mulatta) described in this
study were housed at the New England Primate Research Center (NEPRC) in accordance with
the regulations of the American Association of Accreditation of Laboratory Animal Care and
the standards of the Association for Assessment and Accreditation of Laboratory Animal Care
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International. All protocols and procedures were approved by the relevant Institutional Animal
Care and Use Committee, which was the Harvard Medical Area (HMA) Standing Committee
on Animals at Harvard Medical School. All animals were housed indoors in an SOP-driven,
AAALAC-accredited facility. Husbandry and care met the guidance of the Animal Welfare
Regulations, OLAW reporting and the standards set forth in The Guide for the Care and Use
of Laboratory Animals. All research animals were enrolled in the NEPRC behavioral manage-
ment program, including an IACUC-approved plan for Environmental Enrichment for re-
search primates. This program included regular behavioral assessments, and provision of
species appropriate manipulanda, and foraging opportunities. This protocol had an IACUC-
approved exemption from social housing based on scientific justification. Primary enclosures
consisted of stainless steel primate caging provided by a commercial vendor. Animal body
weights and cage dimensions were regularly monitored. Overall dimensions of primary enclo-
sures (floor area and height) met the specifications of The Guide for the Care and Use of Labo-
ratory Animals, and the Animal Welfare Regulations (AWR’s). Further, all primary enclosures
were sanitized every 14 days at a minimum, in compliance with AWRs. Secondary enclosures
(room level) met specifications of The Guide with respect to temperature, humidity, lighting
and noise level. The animals were provided ad lib access to municipal source water, offered
commercial monkey chow twice daily, and offered fresh produce a minimum of three times
weekly. Light cycle was controlled at 12/12 hours daily. The animals were subject to twice daily
documented observations by trained animal care and veterinary staff, and enrolled in the facil-
ity’s environmental enrichment, and preventative health care programs. Euthanasia took place
at defined experimental endpoints using protocols consistent with the American Veterinary
Medical Association (AVMA) guidelines. Animals were first sedated with intramuscular keta-
mine hydrochloride (20 mg/kg) followed by sodium pentobarbital (100 mg/kg) intravenously
to achieve euthanasia.
Isolation of lymphocytes
Peripheral blood samples were collected from unvaccinated healthy rhesus macaques (n = 5)
for purification of naïve and memory CD8+ T cell subsets, or Mamu-A01+ SIVΔnef-vaccinat-
ed animals (n = 4) at week 5 and week 20 post-vaccination, or Mamu-A01+ wild-type SIV-in-
fected animals (n = 5) at week 20 post-infection, for purification of SIV-specific cells. Blood
was collected in EDTA vacutainer tubes (Becton Dickinson Vacutainer systems, Franklin
Lakes, NJ), and peripheral blood mononuclear cells (PBMC) were separated by density gradi-
ent centrifugation (Lymphocyte Separation Medium; MP Biomedicals Inc., Solon, OH) at 1500
rpm for 45 minutes. PBMC from vaccinated or infected animals were cryopreserved, and sub-
sequently thawed prior to cell sorting. PBMC from healthy uninfected animals were used im-
mediately after separation.
Plasma viral load quantification
Total RNA copy number equivalents were determined in EDTA-treated plasma using a stan-
dardized quantitative real-time RT-PCR assay based on amplification of conserved gag se-
quences as described previously [75]. In wild-type SIV-infected animals, viral loads were
between 22,000 and 1,900,000 copy equivalents/ml plasma at 20 weeks following infection.
Cell sorting
Naïve (CD95−CCR7+ CD28+), central memory (CD95+ CCR7+ CD28+), transitional memory
(CD95+ CCR7−CD28+) and effector memory (CD95+ CCR7− CD28−) CD8+ T cell subsets
were sorted from PBMC from uninfected animals. SIV-specific CD8+ T cells were sorted from
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previously cryopreserved PBMC from SIVmac239Δnef-vaccinated or SIVmac239-infected ani-
mals. SIV-specific CD8+ T cells fromMamu-A01+ or Mamu-A02+ animals were identified
using APC- or PE- conjugated Mamu-A01 or A02 MHC class I tetramers or pentamers
(Proimmune) complexed with the cognate CTL epitope. A01 Gag181–189CM9 [76] and A01
Tat28–35SL8 [77,78] tetramers were kindly provided by Nancy Wilson and David Watkins
(Wisconsin National Primate Research Center, Madison, WI). To identify naïve and memory
phenotypes, PBMC were stained with CD3 (SP34) FITC or Pacific Blue; CD4 (L200)
PerCP-Cy5.5; CD8 (RPA-T8) Alexa 700; CD28 (28.2) ECD (Beckman Coulter), CD95 (DX2)
APC, CCR7 (150503) PE (R&D Systems). Antibodies were obtained from BD Pharmingen un-
less specified. PBMCs (1–2 × 106) were initially labeled with LIVE/DEAD viability stain (Life
Technologies) and washed; incubated with CCR7 antibody for 15 min at 37C; incubated with
tetramers or pentamers for 10 min at RT and washed; then incubated with all other antibodies
for 20 min at RT and washed prior to sorting. Cell sorting was performed on a FACS Aria II
cell sorter (BD Biosciences). Sorts were> 99% pure for all populations, and cell yields generally
ranged between 103 and 105 cells.
RNA extraction, cDNA synthesis and real time PCR
Total RNA was isolated using RNeasy Plus Micro Kit (74034, Qiagen) and quantified from
CD8+ T cells that were FACS purified from PBMC. cDNA was synthesized using the High-
Capacity Reverse Transcription Kit with RNase Inhibitor (4374966, Life Technologies). The re-
sulting cDNA (1ng equivalent input) per reaction was subjected to 18 cycles of preamplifica-
tion using the ABI Preamp Master Mix kit and pooled TaqMan assays (S1 Table) (Applied
Biosystems, Life Technologies). Preamplified cDNAs were diluted 5-fold with 1×TE and loaded
on 96x96 Fluidigm BioMark dynamic arrays (Fluidigm) along with the selected real-time PCR
assays. All possible combinations of samples and assays on the BioMark dynamic array chip
were mixed using the Fluidigm (IFC) integrated fluidic circuit controller. The Fluidigm Bio-
mark System was used for real time PCR amplification and data collection, using 40 cycles of
amplification with real-time monitoring of FAM fluorescence in each well. Initial calculations
of cycle thresholds (Ct) were performed using the Fluidigm BioMark software and further anal-
ysis was carried out using GenEx software (MultiD Analyses, URL: http://www.multid.se). Off-
scale-low expression values were set to maximum onscale Ct+1 for each target transcript. Five
endogenous control genes were included in each Fluidigm run and the stability of endogenous
control genes across all experimental samples was analyzed using the NormFinder algorithm
in GenEx. The mean expression of the two most stable endogenous control genes (PGK1 and
TBP) was used for normalization. Relative expression (2-Δct) values were log2 transformed for
subsequent analyses (S1 Dataset).
Cluster analyses
Unsupervised agglomerative hierarchical clustering was performed on transcript mean-
centered expression values using the Euclidean distance metric and complete linkage clustering
method. Principal component analysis was performed using un-scaled expression values. PCA
heatmap expression values were normalized by scaling expression values to the range of each
transcript. RORC was excluded from PCA analyses because RORC was expressed at or below
the limit of detection in the majority of SIV-specific cells, and chip-to-chip differences in the
values assigned to offscale-low reactions introduced artifacts of apparent differential expression
that confounded PCA plot structure. Clustering analyses were performed using R [79], and the
functions prcomp {stats}, and hclust {stats}. In addition to base R the following R packages
were used: RColorBrewer [80], Plotrix [81], gplots [82], lme4 [83].
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Statistical analyses
Statistical analyses were performed using both Stata software (StataCorp. 2013. Stata Statistical
Software: Release 13. College Station, TX: StataCorp LP) and R [79]. Differences in transcrip-
tion factor expression between sorted naïve and memory subsets, and differences between
sorted subsets and SIV-specific cells were assessed by one-way ANOVA. Differences in princi-
pal component plot positions of SIV-specific cells and sorted naïve and memory cell subsets
were assessed by unpaired Student’s t-test of PC3 values. Differences in principal component
plot positions of week 5 and week 20 post-vaccination samples and of Gag CM9- and Tat
SL8-specific samples were assessed by mixed effects linear regression modeling of PC1 values
of a principal component analysis of SIV-specific cells. Differences between individual tran-
scription factor expression values at week 5 and week 20 post-vaccination or infection, or be-
tween Gag CM9- and Tat SL8-specific cells, were assessed using mixed effects linear regression
models. Differences between individual transcription factor expression values in cells isolated
at 20 weeks post SIVΔnef vaccination and wild-type SIV infection were assessed by unpaired
Student’s t-test. Differences in frequencies of CD8+ T cell memory subsets in Gag CM9- and
Tat SL8-specific cells were assessed by unpaired Student’s t-test (week 5 vs. week 20) or paired
Student’s t-test (Gag vs. Tat.)
Target transcript and Entrez Gene ID
AHR 714254
BATF 702646
BCL6 708736
BCL11B 705238
BCOR 698644
PRDM1 696757
EOMES 704711
ID2 693394
RORC 717052
RORA 704014
PBX3 711691
NFIL3 704757
IRF4 722883
RUNX3 719447
TBX21 694044
TCF7 710234
LEF1 695776
GATA3 713840
Supporting Information
S1 Table. TaqMan assays. The qPCR primer/probe sets (TaqMan assays) used to quantify
mRNA levels of the indicated target transcripts.
(PDF)
S1 Dataset. Expression data. qPCR expression data (log2 2
-Δct).
(XLSX)
S1 Fig. Representative FACS gating. CD8+ naïve and memory T cell subsets (A) and Gag
CM9 and Tat SL8 tetramer/pentamer-sorted CD8+ T cells (B).
(EPS)
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S2 Fig. Memory phenotype of SIV-specific CD8+ T cells and correlation of phenotype with
transcription factor expression profile. (A) Frequencies of CM (CCR7+ CD28+), TM (CCR7-
CD28+), and EM (CCR7- CD28-) populations present in Gag CM9- and Tat SL8-specific CD8+
T cells were analyzed by flow cytometry. Statistically significant (p0.05) differences in fre-
quencies are indicated by bars with asterisks. (B) Pearson’s correlation between the ratio of %
EM to %CM cells and the transcription factor expression profile PCA PC2 value for each sam-
ple of Gag CM9- and Tat SL8-specific CD8+ T cells.
(EPS)
S1 Video. Principal Component Analysis of PC1, PC2 and PC3. Naïve (dark blue), EM
(red), TM (orange), CM (green), week 5 p.v. (pink) and week 20 p.v. (light blue) SIV-specific
cell samples are presented.
(MP4)
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